Figure 9.

Neutralizing antibody data stratified by health status of serum donors. The data presented in Figure 5 were stratified by the health status of the serum donors, showing data from76 healthy serum donors (A), 14 serum donors with LOPD (B), 25 serum donors with muscular dystrophies (C), 26 serum donors with ALS (D), 20 with myotonic disorders (E), 13 with hereditary neuro(no)pathies (F), 24 with other genetic NMD (G) and 11 serum donors with non-genetic NMD (H). Each dot represents an individual sample. Significant differences in neutralizing antibody levels compared to the healthy control group are indicated by * (p < 0.05, Kruskal-Wallis one-way ANOVA on ranks, Dunn´s multiple comparisons test).